Consumer Defensive
Live Price
Offline$15.00
+0.00% today
1Y Change
+1.90%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 254 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rohto Pharmaceutical Co.,Ltd. (RPHCF) is a Consumer Defensive stock with a market cap of $532.71B and listed on OTC. The stock last traded around $15.00 and up 1.9% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +14.0%, EPS growth of +0.4%, a dividend yield of 1.9%. What stands out right now is revenue +14.0%, EPS +0.4%, free cash flow +4.0% with operating margin 11.8% and ROIC 7.9%. The dividend is present but secondary, with a yield around 1.9%. Valuation is more restrained than many high-expectation growth names at P/E 15.5 and price/sales 1.6. Stock Foundry combines RPHCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RPHCF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RPHCF Max Drawdown
-12.02%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RPHCF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$181.1B
-9.3% YoY
FY Net Income
$16.7B
-20.8% YoY
Free Cash Flow
$87.8M
-32.9% YoY
Revenue Growth
+14.0%
EPS Growth
+0.4%
Gross Margin
55.4%
Net Margin
10.3%
Income statement
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 308.6B | 270.8B | 238.7B | 199.6B | 181.1B |
| Gross Profit | 174.9B | 157.3B | 1.0B | 937M | 950M |
| Operating Income | 38.9B | 40.0B | 34.0B | 29.0B | 23.0B |
| EBITDA | 56.4B | 50.4B | 42.3B | 35.8B | 29.9B |
| Net Income | 31.0B | 30.9B | 26.4B | 21.1B | 16.7B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
JPY
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 77.2B | 89.2B | 585M | 582M | 473M |
| Total Assets | 421.9B | 346.2B | 2.3B | 2.3B | 2.0B |
| Total Liabilities | 150.4B | 99.1B | 712M | 747M | 629M |
| Shareholder Equity | 260.1B | 246.3B | 1.6B | 1.5B | 1.4B |
| Total Debt | 50.2B | 10.5B | 102M | 21.4B | 8.1B |
| Net Debt | -26.9B | -78.7B | -482M | -404M | -396M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
181M
-19.1% YoY
Capital Expenditures
93M
-0.2% YoY
Free Cash Flow
88M
-32.9% YoY
Key ratios
Gross Margin
55.4%
Operating Margin
11.8%
Net Margin
10.3%
ROE
12.7%
Debt / Equity
0.18x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.